RNLS and pancreatitis: We found that in our severe pancreatitis model, prophylactic treatment with the renalase peptide (10 mg and 20 mg/kg) significantly reduced histologic injury (edema, inflammation, necrosis, overall histologic severity) and, using immunologic markers, overall inflammation and inflammation by neutrophils and macrophages.